Mahir Kapmaz
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 2
-
- Antibiotic Use and Resistance 2
-
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 and COVID-19 Research 3
- Tuberculosis Research and Epidemiology 2
- Viral gastroenteritis research and epidemiology 1
-
- Long-Term Effects of COVID-19 2
-
- Infectious Diseases and Tuberculosis 2
Mahir Kapmaz
15 papers receiving 232 citations
Peers
Comparison fields: 5 of 60
- Molecular Medicine 65
- Applied Microbiology and Biotechnology 18
- Infectious Diseases 111
- Endocrinology 30
- Neurology 35
Countries citing papers authored by Mahir Kapmaz
This map shows the geographic impact of Mahir Kapmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahir Kapmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahir Kapmaz more than expected).
Fields of papers citing papers by Mahir Kapmaz
This network shows the impact of papers produced by Mahir Kapmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahir Kapmaz. The network helps show where Mahir Kapmaz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mahir Kapmaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 18 | |
| 3 | 2022 | 0 | |
| 4 | 2021 | 5 | |
| 5 | 2021 | 29 | |
| 6 | 2021 | 7 | |
| 7 | 2020 | 23 | |
| 8 | 2020 | 35 | |
| 9 | 2020 | 2 | |
| 10 | 2020 | 1 | |
| 11 | 2019 | 0 | |
| 12 | 2019 | 27 | |
| 13 | 2017 | 47 | |
| 14 | 2016 | 9 | |
| 15 | 2014 | 5 | |
| 16 | 2014 | 2 | |
| 17 | 2007 | 25 |
About Mahir Kapmaz
Mahir Kapmaz is a scholar working on Microbiology, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 17 papers that have together received 236 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Tuberculosis Research and Epidemiology (2 papers), Antibiotic Use and Resistance (2 papers), Antibiotic Resistance in Bacteria (2 papers), Infectious Diseases and Tuberculosis (2 papers), Long-Term Effects of COVID-19 (2 papers) and Viral gastroenteritis research and epidemiology (1 paper). The work is most often cited by research in Molecular Medicine (65 citations), Applied Microbiology and Biotechnology (18 citations) and Infectious Diseases (111 citations). Mahir Kapmaz has collaborated with scholars based in Türkiye, Sweden and Canada. Frequent co-authors include Önder Ergönül, Süda Tekin, Şiran Keske, Seniha Başaran, Füsun Can, Serap Şimşek Yavuz, Şirin Menekşe, Mehtap Aydın, Levent Tabak and Benan Çağlayan. Their work appears in journals such as International Journal of Infectious Diseases, Scientific Reports, Annals of the American Thoracic Society, Journal of Clinical Medicine and Journal of Medical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.